Comparison of solifenacin 5 mg and tolterodine ER 4 mg in the STAR OAB study
Chapple C1, Everaert K2, Lopatkin N3, Katona F4, Melekos M5, Madsen H6, Wright M7, Bolodeoku J7 1. Royal Hallamshire Hospital, Sheffield, UK, 2. Ghent University Hospital, Ghent, Belgium, 3. Moscow Institute of Urology, Moscow, Russia, 4. Josa Andras County Hospital, Nyiregyhaza, Hungary, 5. University of Thessalia, Larissa, Greece, 6. Aalborg Sygehus Nord, Aalborg, Denmark, 7. Astellas Pharma Europe, Staines, UK
|
|
Abstract 89
|
|
|
Clinical Pharmacology:Main Auditorium
Scientific Podium Poster Session 11
|
|
|
Thursday 30th November 2006 |
|
|
15:45 - 15:52 |
|
|